Search - tctmd.com

Displaying 1 - 20 of 128

Sort: Relevancy | Date

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Conference News EHRA 2021

EHRA Updates Its Popular ‘Practical’ NOAC Guide

Todd Neale

April 29, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Conference News ESC 2020

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

Shelley Wood

August 30, 2020

Advertisement

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

What’s Going to Be Hot at ESC 2023?

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Managing AF Patients Undergoing PCI—Some Lingering Questions

Fewer Diabetic Complications Seen When NOACs Given for AF

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

EHRA Updates Its Popular ‘Practical’ NOAC Guide

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Roughly 80% of ESC Guideline Writers Have Financial COIs

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content